Fax: (011) 39 0434 659531
Original Article
Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma†‡§
Article first published online: 16 OCT 2003
DOI: 10.1002/cncr.11816
Copyright © 2003 American Cancer Society
Additional Information
How to Cite
Nasti, G., Martellotta, F., Berretta, M., Mena, M., Fasan, M., Di Perri, G., Talamini, R., Pagano, G., Montroni, M., Cinelli, R., Vaccher, E., D'Arminio Monforte, A. and Tirelli, U. (2003), Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma. Cancer, 98: 2440–2446. doi: 10.1002/cncr.11816
- †
Performed on behalf of the Gruppo Italiano Cooperativo AIDS & Tumori (GICAT) and the Italian Cohort of Naive Antiretroviral Patients (ICONA) study groups.
- ‡
The following are members of the GICAT: Daniele Bernardi, Massimiliano Berretta, Roberta Cinelli, Giampiero di Gennaro, Mariagrazia Michieli, Isabella Milan, Maurizio Rupolo, Ornella Schioppa, Cecilia Simonelli, Michele Spina, Giuseppe Vultaggio, and Martina Zanetti (Aviano, Italy); Pierluigi Blanc (Bagno Ripoli, Italy); Giampiero Carosi and Massimo Puoti (Brescia, Italy); Giuliano Rizzardini and Claudia Zeroli (Busto Arsizio, Italy); Benedetto M. Celesia and Luciano Nigro (Catania, Italy); Ampelio Tocchetti (Como, Italy); Angelo Pan (Cremona, Italy); Francesco Mazzotta (Florence, Italy); Sante Grisorio (Foggia, Italy); Paolo Tundo (Galatina, Italy); Adriana Albini (Genoa, Italy); Marco Fasan, Giuseppe Landonio, Adriano Lazzarin, Carla Pastecchia, and Annalisa Ridolfo (Milan, Italy); Alberto Dolara (Monza, Italy); Vincenzo Montesarchio (Naples, Italy); Pietro L. Garavelli (Novara, Italy); Francesco Di Lorenzo and Salvatrice Mancuso (Palermo, Italy); Guido Chichino and Renato Maserati (Pavia, Italy); Daniela Padrini (Piacenza, Italy); Beatrice Adriani (Prato, Italy); Carla Lovigu (Sassari, Italy); Saverio Di Lorenzo (Sondalo, Italy); Ivano Dal Conte, Ezio Nigra, Filippo Lipani, and Alessandro Sinicco (Turin, Italy); Palma Delle Foglie (Trento, Italy); Alberto Vaglia (Treviso, Italy); Pierluigi Viale (Udine, Italy); and Enzo Raise (Venice, Italy).
- §
The following are members of the ICONA study group: Maria Montroni, Giorgio Scalise, Alessandra Zoli, and S Di Cesare (Ancona, Italy); Umberto Tirelli and Guglielmo Nasti (Aviano, Italy); Giuseppe Pastore, Nicola Ladisa, and Giuseppe Minafra (Bari, Italy); Fredy Suter and Cesare Arici (Bergamo, Italy); Francesco Chiodo, Francesco M. Gritti, Vincenzo Colangeli, Carlo Fiorini, and Lorenzo Guerra (Bologna, Italy); Giampiero Carosi, Gian Pietro Cadeo, Francesco Castelli, Cristina Minardi, and D. Vangi (Brescia, Italy); Giuliano Rizzardini and G. Migliorino (Busto Arsizio, Italy); P.E. Manconi and Paola Piano (Cagliari, Italy); Teresa Ferraro and Alberto Scerbo (Catanzaro, Italy); Eligio Pizzigallo and Francesco Ricci (Chieti, Italy); Domenico Santoro and Luigi Pusterla (Como, Italy); Giuseppe Carnevale and Donata Galloni (Cremona, Italy); Paolo Viganà and Maurizio Mena (Cuggiono, Italy); Florio Ghinelli and Laura Sighinolfi (Ferrara, Italy); Francesco Leoncini, Francesco Mazzotta, Marco Pozzi, and Sergio Lo Caputo (Florence, Italy); Gioacchino Angarano, B. Grisorio, and Sergio Ferrara (Foggia, Italy); Piero Grima and Pietro Tundo (Galatina, Italy); Gabriella Pagano, Nicolò Piersantelli, Alessandro Alessandrini, and Rosita Piscopo (Genoa, Italy); Marcello Toti and Silvia Chigiotti (Grosseto, Italy); Francesco Soscia and Leonardo Tacconi (Latina, Italy); Angiolina Orani and Pietro Perini (Lecco, Italy); Antonio Scasso and Antonella Vincenti (Lucca, Italy); F. Chiodera and P. Castelli (Macerata, Italy); Alfredo Scalzini and Giovanni Fibbia (Mantua, Italy); Marco Moroni, Adriano Lazzarin, Antonio Cargnel, Gian Marco Vigevani, Lucia Caggese, Antonella D'Arminio Monforte, F. Tordato, Rosanna Novati, Antonio Galli, Sergio Merli, Carla Pastecchia, and Cesarina Moioli (Milan, Italy); R. Esposito and Costantino Mussini (Modena, Italy); Nicola Abrescia, Antonio Chirianni, Carolina Izzo, Marcello Piazza, Massimo De Marco, Vincenzo Montesarchio, E. Manzillo, and Salvatore Nappa (Naples, Italy); Angelo Colomba, Vincenzo Abbadessa, Vincenzo Prestileo, and Salvatrice Mancuso (Palermo, Italy); Claudio Ferrari and Paolo Pizzaferri (Parma, Italy); Gaetano Filice, Lorenzo Minoli, Roberto Bruno, and Renato Maserati (Pavia, Italy); Sergio Pauluzzi and F. Baldelli (Perugia, Italy); Enzo Petrelli and Anna Cioppi (Pesaro, Italy); Fabio Alberici and Antonio Ruggieri (Piacenza, Italy); Francesco Menichetti and Canio Martinelli (Pisa, Italy); Carlo De Stefano and Angela La Gala (Potenza, Italy); Tiziano Zauli and G. Ballardini (Ravenna, Italy); Giacomo Magnani and Alessandra Ursitti (Reggio Emilia, Italy); Marco Arlotti and P. Ortolani (Rimini, Italy); Luigi Ortona, Ferdinando Dianzani, Giuseppe Ippolito, Andrea Antinori, Giorio Antonucci, S. D'Elia, Pasquale Narciso, N. Petrosillo, Vincenzo Vullo, A. De Luca, L. Del Forno, Mauro Zaccarelli, Patrizio De Longis, M. Ciardi, G. D'Offizi, Pietro Noto, Maurizio Lichtner, Maria Rosa Capobianchi, E. Girardi, Patrizio Pezzotti, and Giovanni Rezza (Rome, Italy); M.S. Mura and M. Mannazzu (Sassari, Italy); Pietro Caramello, Alessandro Sinicco, Maria Luisa Soranzo, L. Gennero, M. Sciandra, and Bernardino Salassa (Turin, Italy); P.A. Grossi and Claudio Basilico (Varese, Italy); A. Poggio and G. Bottari (Verbania, Italy); Enzo Raise and Sandro Pasquinucci (Venice, Italy); Fausto De Lalla and G. Tositti (Vicenza, Italy); Francesco Resta and Antonio Chimienti (Taranto, Italy); and A. Cozzi Lepri (London, United Kingdom).
Publication History
- Issue published online: 17 NOV 2003
- Article first published online: 16 OCT 2003
- Manuscript Accepted: 19 AUG 2003
- Manuscript Revised: 13 AUG 2003
- Manuscript Received: 15 MAY 2003
Funded by
- Associazione Italiana per la Ricerca sul Cancro
- Istituto Superiore di Sanitá
REFERENCES
- 1, , . Changing incidence of AIDS-defining illness in the era of antiretroviral combination therapy. AIDS. 1997; 11: 1731–1738.
- 2, , , et al. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphomas among HIV-1-infected individuals. J Acquir Immune Defic Syndr. 1999; 21: S34–S41.
- 3, , , et al. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. J Acquir Immune Defic Syndr. 1999; 21: S11–S17.
- 4, , , et al. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. AIDS. 2000; 14: 987–993.
- 5, , , et al. HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy. J Acquir Immune Defic Syndr. 1999; 22: 407–408.
- 6, , , et al. Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome. Eur J Cancer. 1999; 15: 1809–1815.
- 7. New therapies for the treatment of AIDS-related Kaposi's sarcoma. Curr Opin Oncol. 2000; 12: 445–449.
- 8, , , et al. Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma. Ann Oncol. 1998; 9: 923.
- 9, , , et al. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS. 1998; 12: F45–F49.
- 10, , , et al. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. Drug Saf. 1999; 20: 403–425.
- 11, . Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 1998; 9: 63–83.
- 12, , . Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response and staging criteria. J Clin Oncol. 1989; 7: 1201–1207.
- 13, . Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457–481.
- 14, , , et al. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi's sarcoma or non-Hodgkin's lymphoma. Int J Cancer. 2002; 98: 916–922.Direct Link:
- 15, , , et al. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. AIDS. 1999; 13: 2105–2111.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)